Recent updates on central nervous system prophylaxis in patients with high-risk diffuse large B-cell lymphoma

Recent updates on central nervous system prophylaxis in patients with high-risk diffuse large B-cell lymphoma

Abstract The use of central nervous system (CNS) prophylaxis for patients with diffuse large B-cell lymphoma (DLBCL) remains controversial. Although uncommon, CNS relapses are invariably fatal in this otherwise curable disease. Accurate identification of patients at risk and the optimal approach to...

Full description

Bibliographic Details
Main Authors: Bernard Ji Guang Chua, Chen Ee Low, Chun En Yau, Ya Hwee Tan, Jianbang Chiang, Esther Wei Yin Chang, Jason Yongsheng Chan, Eileen Yi Ling Poon, Nagavalli Somasundaram, Mohamed Farid Bin Harunal Rashid, Miriam Tao, Soon Thye Lim, Valerie Shiwen Yang
Format: Article
Language:English
Published: BMC 2024-01-01
Series:Experimental Hematology & Oncology
Subjects:
Diffuse Large B-Cell Lymphoma
Non-Hodgkin’s Lymphoma
Central Nervous System
CNS Prophylaxis
Methotrexate
Online Access:https://doi.org/10.1186/s40164-023-00467-2

Internet

https://doi.org/10.1186/s40164-023-00467-2

Similar Items